Evora Biosciences
PrivateLast Round
Grant
Dec 6, 2021
Total Funding Raised
$939,000
Company Overview
Evora Biosciences operates in Healthcare & Life Sciences and is based in Illkirch-Graffenstaden. Its latest recorded funding round was a Grant round in December 2021.
Evora Biosciences is a biotechnology company that develops novel immunomodulatory lipopeptides and exosome-based therapies for autoimmune and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evora Biosciences Comparables
Compare Evora Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RION | 65% | |
| Direct Biologics | 64% | |
| Takeda | 63% |
For institutional investors. Book with your work email.
Evora Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 6, 2021 | ||||
| Grant | Jul 8, 2021 | ||||
| Grant | Jun 3, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Evora Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| WeLikeStartup | Angel |
| EIT Health | Grant |
| Wilco | Angel, Accelerator |
| Erganeo | Angel |
| Bpifrance | Grant |
| Investessor | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 65% MoM.
- Apr 19, 2026
Monthly visitors increased 79% MoM.
For institutional investors. Book with your work email.
Evora Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Evora Biosciences's valuation, stock price, and market status.
Is Evora Biosciences a public or private company?
Evora Biosciences is a private company.
What is the current stock price of Evora Biosciences?
Evora Biosciences is a private company, so its shares have no public market price. Caplight tracks Evora Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Evora Biosciences worth (valuation)?
Valuation information for Evora Biosciences is not publicly available.
Can I buy Evora Biosciences stock?
Evora Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Evora Biosciences's last funding round?
Evora Biosciences's most recent funding round was Grant on December 6, 2021.
Who are the main investors in Evora Biosciences?
Key investors in Evora Biosciences include EIT Health, Wilco, Bpifrance.
Will Evora Biosciences IPO soon?
No public IPO plans have been announced for Evora Biosciences.
How can I track Evora Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Evora Biosciences's shares on secondary markets.